SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001047469-18-007597
Filing Date
2018-12-11
Accepted
2018-12-11 17:07:17
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 a2237233zs-3.htm S-3 186929
2 EX-4.8 a2237233zex-4_8.htm EX-4.8 22780
3 EX-5.1 a2237233zex-5_1.htm EX-5.1 6846
4 EX-23.1 a2237233zex-23_1.htm EX-23.1 3265
5 G1027756.JPG g1027756.jpg GRAPHIC 26526
  Complete submission text file 0001047469-18-007597.txt   257488
Mailing Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050
Business Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050 972.408.1360
Neos Therapeutics, Inc. (Filer) CIK: 0001467652 (see all company filings)

IRS No.: 270395455 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-228748 | Film No.: 181229407
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1